Home › Trial NCT07657884
Assessment of the Usefulness of SMI (Superb Vascular Imaging) for the Characterisation of Pancreatic Cystic Tumours (IMAKYST)
- Trial IDNCT07657884
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
- Enrollment60
- Start date2026-05-15
- ConditionsSerous Cystadenoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.